Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Un Pae

Showing results (61-70 of 387) with videos related to

Pageof 39
Sort By:
Expert Review of Neurotherapeutics|February 9, 2007
Paroxetine: current status in psychiatryChi-Un Pae, Ashwin A Patkar
Expert Review of Neurotherapeutics|August 23, 2013
How much to worry about the FDA warning in the use of citalopram?Sheng-Min Wang, Chi-Un Pae
CNS Drugs|May 28, 2013
Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorderAshwin A Patkar, Chi-Un Pae
The Journal of Clinical Psychiatry|April 2, 2015
Cognitive dysfunction in psychiatric illness: a neglected domainPrakash S Masand, Chi-Un Pae
Psychiatry Research|May 18, 2010
Influence of DAOA gene variants on antipsychotic response after switch to aripiprazoleChi-Un Pae, Alberto Chiesa, Alessandro Serretti
Expert Review of Neurotherapeutics|January 31, 2017
Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?Prakash Masand, Changsu Han, Chi-Un Pae
Medical Hypotheses|December 15, 2006
Therapeutic possibilities of cysteamine in the treatment of schizophreniaChi-Un Pae, Chul Lee, In-Ho Paik
Expert Opinion on Investigational Drugs|December 23, 2014
Criticisms of drugs in early development for the treatment of depression: what can be improved?Sheng-Min Wang, Changsu Han, Chi-Un Pae
Psychiatry Investigation|January 5, 2010
Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approachesDavid M Marks, Thanaseelan J, Chi-Un Pae
Medical Hypotheses|January 2, 2007
Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depressionChi-Un Pae, Chul Lee, In-Ho Paik
Pageof 39

Showing results (61-70 of 387) with videos related to

Sort By:
Pageof 39
Expert Review of Neurotherapeutics|February 9, 2007
Paroxetine: current status in psychiatryChi-Un Pae, Ashwin A Patkar
Expert Review of Neurotherapeutics|August 23, 2013
How much to worry about the FDA warning in the use of citalopram?Sheng-Min Wang, Chi-Un Pae
CNS Drugs|May 28, 2013
Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorderAshwin A Patkar, Chi-Un Pae
The Journal of Clinical Psychiatry|April 2, 2015
Cognitive dysfunction in psychiatric illness: a neglected domainPrakash S Masand, Chi-Un Pae
Psychiatry Research|May 18, 2010
Influence of DAOA gene variants on antipsychotic response after switch to aripiprazoleChi-Un Pae, Alberto Chiesa, Alessandro Serretti
Expert Review of Neurotherapeutics|January 31, 2017
Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?Prakash Masand, Changsu Han, Chi-Un Pae
Medical Hypotheses|December 15, 2006
Therapeutic possibilities of cysteamine in the treatment of schizophreniaChi-Un Pae, Chul Lee, In-Ho Paik
Expert Opinion on Investigational Drugs|December 23, 2014
Criticisms of drugs in early development for the treatment of depression: what can be improved?Sheng-Min Wang, Changsu Han, Chi-Un Pae
Psychiatry Investigation|January 5, 2010
Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approachesDavid M Marks, Thanaseelan J, Chi-Un Pae
Medical Hypotheses|January 2, 2007
Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depressionChi-Un Pae, Chul Lee, In-Ho Paik
Pageof 39